Steatohepatitis: A tale of two “hits”?

Day, 1994, The biochemistry of alcoholic fatty liver, Biochim Biophys Acta, 1215, 33, 10.1016/0005-2760(94)90089-2 Braillon, 1985, Liver in obsesity, Gut, 26, 133, 10.1136/gut.26.2.133 Fromenty, 1995, Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity, Pharmacol Ther, 67, 101, 10.1016/0163-7258(95)00012-6 Bacon, 1994, Nonalcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6 Diehl, 1988, Alcohollike liver disease in nonalcoholics, Gastroenterology, 95, 1056, 10.1016/0016-5085(88)90183-7 Teli, 1995, The natural history of non-alcoholic fatty liver: a follow-up study, Hepatology, 22, 1714, 10.1002/hep.1840220616 Berson, 1998, Steatohepati-tis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes, Gastroenterology, 114, 764, 10.1016/S0016-5085(98)70590-6 Nordmann, 1992, Implication of free radical mechanisms in ethanol induced cellular injury, Free Radic Biol Med, 12, 219, 10.1016/0891-5849(92)90030-K Day, 1996, Is necroinflammation a prerequisite for fibrogenesis?, Hepatogastroenterology, 43, 104 Misra, 1992, Chronic ethanol treatment induces H2O2 production selectively in pericentral regions of the liver lobule, Alcohol Clin Exp Res, 16, 839, 10.1111/j.1530-0277.1992.tb01878.x Albano, 1996, Role of cytochrome P4502E1–dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol, Hepatology, 23, 155, 10.1002/hep.510230121 Letteron, 1996, Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice, J Hepatol, 24, 200, 10.1016/S0168-8278(96)80030-4 Weltmann, 1996, Evidence that oxidative stress plays a role in steatohepatitis produced in a rat nutritional model, Hepatology, 24, 240A Pinto, 1996, Hepatic steatosis and lipid peroxidation in human chronic liver diseases, Hepatology, 24, 311A Parola, 1993, Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1(I) gene expression in human liver fat-storing cells, Biochim Biophys Res Commun, 194, 1044, 10.1006/bbrc.1993.1927 Lee, 1995, Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression, J Clin Invest, 96, 2461, 10.1172/JCI118304 Curzio, 1985, Chemotactic activity of hydroxyalkenals on rat neutrophils, Int J Tissue React, 7, 137 Jaeschke, 1996, Reactive oxygen species activate the transcription factor NF-κB in the liver by induction of lipid peroxidation, Hepatology, 24, 238A Baeuerle, 1994, Function and activation of NF-κB in the immune system, Annu Rev Immunol, 12, 141, 10.1146/annurev.iy.12.040194.001041 Pessayre, 1979, Perhexiline-maleate induced cirrhosis, Gastroenterology, 76, 170, 10.1016/S0016-5085(79)80145-6 Simon, 1984, Amiodarone hepatotoxicity simulating alcoholic liver disease, N Engl J Med, 311, 167, 10.1056/NEJM198407193110308 Fromenty, 1990, Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice, J Pharmacol Exp Ther, 255, 1371 Fromenty, 1990, Dual effect of amiodarone on mitochondrial respiration, initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II, J Pharmacol Exp Ther, 255, 1377 Deschamps, 1994, Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic lesions, Hepatology, 19, 948, 10.1002/hep.1840190422 Garcia-Ruiz, 1995, Role of oxidative stress generated from mitochondrial electron transport chain and mitochondrial electron status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes, Mol Pharmacol, 48, 825 Takahashi, 1992, Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P-450 (CYP 2E1) in the liver of rats chronically fed ethanol, Pharmacol Toxicol, 70, 347, 10.1111/j.1600-0773.1992.tb00485.x Tsukamoto, 1995, Experimental liver cirrhosis induced by alcohol and iron, J Clin Invest, 96, 620, 10.1172/JCI118077 Hall, 1991, Hepatic fibrosis and cirrhosis after chronic administration of alcohol and “low-dose” carbon tetrachloride vapour in the rat, Hepatology, 13, 815, 10.1016/0270-9139(91)90246-R Grove J, Daly AK, Brown AStJM, Bassendine MF, James OFW, Day CP. The Rsa I polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics (in press). Weltmann, 1996, Hepatic CYP2E1 is increased in patients with non-alcoholic steatohepatitis, Hepatology, 24, 202A Weltmann, 1996, Increased CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation, Gastroenterology, 111, 1645, 10.1016/S0016-5085(96)70028-8 Zangar, 1997, Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes, Arch Biochem Biophys, 337, 217, 10.1006/abbi.1996.9785 Ockner, 1993, Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis, Hepatology, 18, 669, 10.1002/hep.1840180327 George, 1998, Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis, Gastroenterology, 114, 311, 10.1016/S0016-5085(98)70482-2